Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=60

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT05437510-86f9125c",
        "title": "Nirsevimab vs No Intervention: Number of Participants With Non-Serious Treatment-Emergent Adverse Events",
        "summary": "1316 of 4016 against 1265 of 4018; risk difference 1.3 points, 95% interval -0.8 to 3.3; NCT05437510, Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life",
        "record": "/library/comparisons/NCT05437510-86f9125c",
        "nct_id": "NCT05437510",
        "kind": "outcome",
        "participants": 8034,
        "risk_difference": {
          "value": 0.012855992654568382,
          "lower": -0.007564261935912604,
          "upper": 0.03326160134621879
        },
        "group_1": "1,316 of 4,016",
        "group_2": "1,265 of 4,018",
        "difference": "1.3 points",
        "interval": "-0.8 to 3.3",
        "trial_title": "Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life"
      },
      {
        "id": "NCT05437510-deaths",
        "title": "Nirsevimab vs No Intervention: deaths from any cause",
        "summary": "1 of 4016 against 0 of 4018; risk difference 0.0 points, 95% interval -0.1 to 0.1; NCT05437510, Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life",
        "record": "/library/comparisons/NCT05437510-deaths",
        "nct_id": "NCT05437510",
        "kind": "deaths",
        "participants": 8034,
        "risk_difference": {
          "value": 0.000249003984063745,
          "lower": -0.0007279066953194914,
          "upper": 0.0014091998490194757
        },
        "group_1": "1 of 4,016",
        "group_2": "0 of 4,018",
        "difference": "0.0 points",
        "interval": "-0.1 to 0.1",
        "trial_title": "Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=61",
  "request_id": "sEby09d-JNUdLGeG"
}